A new study has found that for people with moderate hearing loss, being prescribed hearing aids had little impact on cognitive test scores. The study was published on… read more.
Despite years of clinical guidelines warning against the practice, one in four Medicare beneficiaries with dementia is prescribed brain-altering medications linked to falls, confusion, and hospitalization, according to… read more.
A major review of prior research has found no evidence that menopause hormone therapy either increases or decreases dementia risk in post-menopausal women, in a new study led… read more.
Most studies investigating the impact of sleep deprivation and circadian rhythm disruption on concentration and work performance have relied on self-reported questionnaires or small-scale surveys. To achieve an… read more.
Annual prescriptions for drugs to treat attention-deficit/hyperactivity disorder (ADHD) increased 157 percent in Ontario from 2015 to 2023, according to a new study from researchers at ICES, North… read more.
Acadia Pharmaceuticals announced that the FDA has approved Daybue Stix (trofinetide) for oral solution, a dye- and preservative-free powder formulation of trofinetide for the treatment of Rett syndrome… read more.
Axogen, Inc. announced that the FDA has approved the Biologics License Application (“BLA”) for Avance (acellular nerve allograft-arwx). Avance is an acellular nerve scaffold for the treatment of… read more.
People with impaired kidney function have higher levels of Alzheimer’s biomarkers in their blood, but not an increased risk of dementia, according to a study published December 3,… read more.
Lundbeck A/S (Lundbeck) announced that new pipeline data regarding bexicaserin (LP352), a novel investigational drug for the treatment of seizures associated with Developmental and Epileptic Encephalopathies (DEEs), will… read more.
UCB, a global biopharmaceutical company, today announced it will present 21 abstracts at the American Epilepsy Society (AES) Annual Meeting (December 5-9, 2025). Data include primary efficacy and… read more.
Xenon Pharmaceuticals Inc, a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, announced multiple presentations at the upcoming American… read more.
A new study shows large increases in the use of computed tomography (CT) scans of the head in emergency departments across the United States from 2007 to 2022…. read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
